Phase 2 Study of Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2016
At a glance
- Drugs Nimotuzumab (Primary) ; Temozolomide
- Indications Brain cancer
- Focus Adverse reactions
- 31 Mar 2016 Planned End Date changed from 1 Aug 2016 to 1 Aug 2017, as reported by ClinicalTrials.gov.
- 31 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Jan 2017, as reported by ClinicalTrials.gov.
- 16 Feb 2016 New trial record